These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Mitochondrial diabetes: clinical features, diagnosis and management]. Meas T; Laloi-Michelin M; Virally M; Ambonville C; Kevorkian JP; Guillausseau PJ Rev Med Interne; 2010 Mar; 31(3):216-21. PubMed ID: 19299044 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial diseases. Gorman GS; Chinnery PF; DiMauro S; Hirano M; Koga Y; McFarland R; Suomalainen A; Thorburn DR; Zeviani M; Turnbull DM Nat Rev Dis Primers; 2016 Oct; 2():16080. PubMed ID: 27775730 [TBL] [Abstract][Full Text] [Related]
5. Endocrine features of primary mitochondrial diseases. Romo L; Gold NB; Walker MA Curr Opin Endocrinol Diabetes Obes; 2024 Feb; 31(1):34-42. PubMed ID: 38047549 [TBL] [Abstract][Full Text] [Related]
6. The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management. Nesbitt V; Pitceathly RD; Turnbull DM; Taylor RW; Sweeney MG; Mudanohwo EE; Rahman S; Hanna MG; McFarland R J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):936-8. PubMed ID: 23355809 [TBL] [Abstract][Full Text] [Related]
7. Endocrine disorders in mitochondrial disease. Schaefer AM; Walker M; Turnbull DM; Taylor RW Mol Cell Endocrinol; 2013 Oct; 379(1-2):2-11. PubMed ID: 23769710 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial disease in adults: recent advances and future promise. Ng YS; Bindoff LA; Gorman GS; Klopstock T; Kornblum C; Mancuso M; McFarland R; Sue CM; Suomalainen A; Taylor RW; Thorburn DR; Turnbull DM Lancet Neurol; 2021 Jul; 20(7):573-584. PubMed ID: 34146515 [TBL] [Abstract][Full Text] [Related]
9. [Diabetes and hypokinetic cardiopathy : when to consider mitochondrial disease?]. Nozières C; Quillasi V; Mouly-Bertin C; Thomson V; Gachon-Lanier E; Lantelme P Ann Cardiol Angeiol (Paris); 2011 Jun; 60(3):176-8. PubMed ID: 20851378 [TBL] [Abstract][Full Text] [Related]
10. Recognition, investigation and management of mitochondrial disease. Davison JE; Rahman S Arch Dis Child; 2017 Nov; 102(11):1082-1090. PubMed ID: 28647693 [TBL] [Abstract][Full Text] [Related]
11. One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation. Esterhuizen K; Lindeque JZ; Mason S; van der Westhuizen FH; Rodenburg RJ; de Laat P; Smeitink JAM; Janssen MCH; Louw R Metabolomics; 2021 Jan; 17(1):10. PubMed ID: 33438095 [TBL] [Abstract][Full Text] [Related]
12. THE ROLE OF HETEROPLASMY IN THE DIAGNOSIS AND MANAGEMENT OF MATERNALLY INHERITED DIABETES AND DEAFNESS. Robinson KN; Terrazas S; Giordano-Mooga S; Xavier NA Endocr Pract; 2020 Feb; 26(2):241-246. PubMed ID: 31682520 [No Abstract] [Full Text] [Related]
13. Mutations causing mitochondrial disease: What is new and what challenges remain? Lightowlers RN; Taylor RW; Turnbull DM Science; 2015 Sep; 349(6255):1494-9. PubMed ID: 26404827 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial diseases. Davis RL; Liang C; Sue CM Handb Clin Neurol; 2018; 147():125-141. PubMed ID: 29325608 [TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing for mitochondrial disorders. Carroll CJ; Brilhante V; Suomalainen A Br J Pharmacol; 2014 Apr; 171(8):1837-53. PubMed ID: 24138576 [TBL] [Abstract][Full Text] [Related]
19. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Murphy R; Turnbull DM; Walker M; Hattersley AT Diabet Med; 2008 Apr; 25(4):383-99. PubMed ID: 18294221 [TBL] [Abstract][Full Text] [Related]
20. [Diagnostic and Therapeutic Approaches for Mitochondrial Diseases]. Radelfahr F; Klopstock T Fortschr Neurol Psychiatr; 2018 Sep; 86(9):584-591. PubMed ID: 30248691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]